For instance, studies in melanoma [45], urothelial carcinoma [46], and HCC [12] have found that PD-L1 expression on nontumor host cells, such as TILs, was associated with response to anti-PD1 or anti-PD-L1 therapy. The gene discussed is CD274; the disease is melanoma.